RAAPID INC
PrivateLast Round
Series A
Extension
Mar 18, 2026
Total Funding Raised
$6.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
RAAPID INC operates in Healthcare & Life Sciences and is based in Louisville, Kentucky. Its latest recorded funding round was a Series A Extension round in March 2026.
RAAPID INC is a healthcare AI company that provides a neuro-symbolic AI platform to automate and improve healthcare risk adjustment for payers and providers.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Revenue Cycle, Compliance & Risk, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAAPID INC Comparables
Compare RAAPID INC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Foresee Medical, Inc. | 84% | |
| Datavant | 81% | |
| Reveleer | 80% |
For institutional investors. Book with your work email.
RAAPID INC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 18, 2026 | ||||
| Series A | Jan 10, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
RAAPID INC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Healthworx | Series A Extension, Series A |
| Crosslink Capital | Series A |
| M12 - Microsoft's Venture Fund | Series A Extension, Series A |
| Cervin Ventures | Series A |
| UPMC Enterprises | Series A, Series A Extension |
| Thomvest Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Company job posting cites certification as a Great Place to Work.
- Jul 1, 2026
Achieved SOC 2 Type II certification.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asAug 26, 2026
RAAPID, Inc. earns the top spot in a ranking of seven Medicare risk adjustment software tools for 2026 for its evidence-first approach and two-way code review on Aug 26th '26.
For institutional investors. Book with your work email.
RAAPID INC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RAAPID INC's valuation, stock price, and market status.
Is RAAPID INC a public or private company?
RAAPID INC is a private company.
What is the current stock price of RAAPID INC?
RAAPID INC is a private company, so its shares have no public market price. Caplight tracks RAAPID INC's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RAAPID INC worth (valuation)?
Valuation information for RAAPID INC is not publicly available.
Can I buy RAAPID INC stock?
RAAPID INC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RAAPID INC's last funding round?
RAAPID INC's most recent funding round was Series A Extension on March 18, 2026.
Who are the main investors in RAAPID INC?
Key investors in RAAPID INC include M12 - Microsoft's Venture Fund, UPMC Enterprises.
Will RAAPID INC IPO soon?
No public IPO plans have been announced for RAAPID INC.
How can I track RAAPID INC secondary market activity?
Caplight tracks bids, offers, and trades in RAAPID INC's shares on secondary markets.